From The Economic Times
Center-Right Owned by Bennett, Coleman & Co.NATCO Pharma subsidiary launches Carboplatin in US market to address shortages
RSS excerpt
Indian pharmaceutical company NATCO Pharma annouced the launch of Carboplatin Injection, a generic version of Paraplatin in the US market by its American subsidiary. The subsidiary would collaborate in manufacturing with Chennai-based Tero Labs Pvt Ltd. The launch is aimed at meeting the shortage of…
